Bayesian Capital Management, LP Mimedx Group, Inc. Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.16 - $8.08 $67,821 - $88,960	11,010 New	11,010 $76,000
Q4 2023 Feb 14, 2024	BUY	$5.7 - $9.14 $58,818 - $94,315	10,319 New	10,319 $90,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $5.0 $39,729 - $62,665	12,533 New	12,533 $43,000
Q4 2017 Feb 12, 2018	SELL	$10.87 - $13.9 $114,134 - $145,950	-10,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.86 - $17.34 $124,530 - $182,070	10,500	10,500 $125,000

209

98.2M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.05B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.